Viewing Study NCT06533332

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:56 PM
Ignite Modification Date: 2026-04-02 @ 8:52 AM
Study NCT ID: NCT06533332
Status: RECRUITING
Last Update Posted: 2025-09-18
First Post: 2024-07-22
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors
Sponsor: EtiraRx Australia Pty Ltd
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumor View
None Metastatic Breast Cancer View
None Metastatic Ovarian Cancer View
None Metastatic Endometrial Cancer View
None Metastatic Liver Cancer View
None Metastatic Pancreatic Cancer View
Keywords: